These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 1315253)
21. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma. Szereday Z; Schally AV; Varga JL; Kanashiro CA; Hebert F; Armatis P; Groot K; Szepeshazi K; Halmos G; Busto R Cancer Res; 2003 Nov; 63(22):7913-9. PubMed ID: 14633721 [TBL] [Abstract][Full Text] [Related]
22. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats. Domené H; Krishnamurthi K; Eshet R; Gilad I; Laron Z; Koch I; Stannard B; Cassorla F; Roberts CT; LeRoith D Endocrinology; 1993 Aug; 133(2):675-82. PubMed ID: 7688291 [TBL] [Abstract][Full Text] [Related]
23. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action. Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358 [TBL] [Abstract][Full Text] [Related]
24. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels. Kineman RD; Kamegai J; Frohman LA Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214 [TBL] [Abstract][Full Text] [Related]
25. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Sato M; Frohman LA Endocrinology; 1993 Aug; 133(2):793-9. PubMed ID: 8102097 [TBL] [Abstract][Full Text] [Related]
26. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Ionescu M; Frohman LA J Clin Endocrinol Metab; 2006 Dec; 91(12):4792-7. PubMed ID: 17018654 [TBL] [Abstract][Full Text] [Related]
27. Antagonist to GH-releasing factor inhibits growth and renal Pi reabsorption in immature rats. Mulroney SE; Lumpkin MD; Haramati A Am J Physiol; 1989 Jul; 257(1 Pt 2):F29-34. PubMed ID: 2502027 [TBL] [Abstract][Full Text] [Related]
28. Growth hormone regulation of glomerular AT1 angiotensin receptors in adult uninephrectomized male rats. Mok KY; Sandberg K; Sweeny JM; Zheng W; Lee S; Mulroney SE Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1085-91. PubMed ID: 12824079 [TBL] [Abstract][Full Text] [Related]
30. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Ceda GP; Davis RG; Rosenfeld RG; Hoffman AR Endocrinology; 1987 Apr; 120(4):1658-62. PubMed ID: 3104015 [TBL] [Abstract][Full Text] [Related]
31. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat. Melián E; Velasco B; Barrios R; Sanchez-Franco F Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610 [TBL] [Abstract][Full Text] [Related]
32. Regulation of somatic growth and the somatotropic axis by gonadal steroids: primary effect on insulin-like growth factor I gene expression and secretion. Borski RJ; Tsai W; DeMott-Friberg R; Barkan AL Endocrinology; 1996 Aug; 137(8):3253-9. PubMed ID: 8754747 [TBL] [Abstract][Full Text] [Related]
33. Hormonal regulation of rat hypothalamic neuropeptide mRNAs: effect of hypophysectomy and hormone replacement on growth-hormone-releasing factor, somatostatin and the insulin-like growth factors. Wood TL; Berelowitz M; Gelato MC; Roberts CT; LeRoith D; Millard WJ; McKelvy JF Neuroendocrinology; 1991 Mar; 53(3):298-305. PubMed ID: 1674982 [TBL] [Abstract][Full Text] [Related]
34. Regulation of growth hormone (GH) secretion by GH-releasing factor, somatostatin, and insulin-like growth factor I in ovine fetal and neonatal pituitary cells in vitro. Silverman BL; Bettendorf M; Kaplan SL; Grumbach MM; Miller WL Endocrinology; 1989 Jan; 124(1):84-9. PubMed ID: 2562828 [TBL] [Abstract][Full Text] [Related]
36. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-I levels in old men. Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR J Clin Endocrinol Metab; 1993 Jan; 76(1):134-8. PubMed ID: 8421077 [TBL] [Abstract][Full Text] [Related]
37. Delayed age-associated decrease in growth hormone pulsatile secretion and increased orexigenic peptide expression in the Lou C/JaLL rat. Kappeler L; Zizzari P; Alliot J; Epelbaum J; Bluet-Pajot MT Neuroendocrinology; 2004; 80(5):273-83. PubMed ID: 15677878 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of ethanol on the growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-I axis in the rat. Soszynski PA; Frohman LA Endocrinology; 1992 Dec; 131(6):2603-8. PubMed ID: 1359962 [TBL] [Abstract][Full Text] [Related]
39. Plasma growth hormone (GH) response to intravenous GH-releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation. Arsenijevic Y; Rivest RW; Eshkol A; Sizonenko PC; Aubert ML Endocrinology; 1987 Oct; 121(4):1487-96. PubMed ID: 2888646 [TBL] [Abstract][Full Text] [Related]